Severe Acute Respiratory Syndrome (SARS) Pneumonia
Showing 1 - 25 of >10,000
Respiratory Viral Infection, Common Cold, Severe Acute Respiratory Syndrome (SARS) Pneumonia Trial in Vienna (nasal spray)
Completed
- Respiratory Viral Infection
- +4 more
- nasal spray
-
Vienna, Austria
- +1 more
Aug 24, 2022
Severe Acute Respiratory Syndrome (SARS), Acute Respiratory Distress Syndrome (ARDS), Pneumonia Trial in Salvador (intravenous
Not yet recruiting
- Severe Acute Respiratory Syndrome (SARS)
- +2 more
- intravenous treatment with EVs
- intravenous treatment with placebo solution
-
Salvador, Bahia, BrazilHospital São Rafael
Aug 18, 2023
Pneumonia, Coronavirus Infection in 2019 (COVID-19), Severe Acute Respiratory Syndrome (SARS) Pneumonia Trial in Atlanta (Low
Terminated
- Pneumonia
- +2 more
- Low Dose Radiation Therapy
-
Atlanta, Georgia
- +1 more
Mar 14, 2022
Severe Acute Respiratory Syndrome (SARS) Pneumonia, COVID-19 Pneumonia Trial in Germany (Molgramostim nebuliser solution,
Active, not recruiting
- Severe Acute Respiratory Syndrome (SARS) Pneumonia
- COVID-19 Pneumonia
- Molgramostim nebuliser solution
- Placebo nebuliser solution
-
Dresden, Germany
- +8 more
Jun 20, 2022
Practice Variation on Antithrombotics in COVID-19
Completed
- COVID-19 Pneumonia
- +3 more
- Current clinical practices of participating physicians
-
Mumbai, Mumbai, Mahrastra, IndiaReliance Hospital
Nov 23, 2021
SARS-CoV Infection, Severe Acute Respiratory Syndrome (SARS) Pneumonia Trial in Manaus (Methylprednisolone Sodium Succinate,
Completed
- SARS-CoV Infection
- Severe Acute Respiratory Syndrome (SARS) Pneumonia
- Methylprednisolone Sodium Succinate
- Placebo solution
-
Manaus, Amazonas, BrazilHospital e Pronto Socorro Delphina Rinaldi Abdel Aziz
Jul 21, 2021
COVID-19, SARS-CoV Infection, SARS (Severe Acute Respiratory Syndrome) Trial in Mexico DF (Glycine)
Terminated
- COVID-19
- +5 more
- Glycine
-
Mexico DF, MexicoInstituto Nacional de Enfermedades Respiratorias
Aug 2, 2022
SARS-CoV Infection, Severe Acute Respiratory Syndrome (SARS) Pneumonia Trial in Manaus (Chloroquine diphosphate)
Completed
- SARS-CoV Infection
- Severe Acute Respiratory Syndrome (SARS) Pneumonia
- Chloroquine diphosphate
-
Manaus, Amazonas, BrazilHospital e Pronto Socorro Delphina Rinaldi Abdel Aziz
Aug 2, 2021
Severe Acute Respiratory Syndrome (SARS) Pneumonia Trial (Stem Cell Educator-Treated Mononuclear Cells Apheresis)
Not yet recruiting
- Severe Acute Respiratory Syndrome (SARS) Pneumonia
- Stem Cell Educator-Treated Mononuclear Cells Apheresis
- (no location specified)
Jun 25, 2021
COVID-19, SARS-CoV Infection, Severe Acute Respiratory Syndrome (SARS) Pneumonia Trial in Manaus (Chloroquine Diphosphate,
Completed
- COVID-19
- +3 more
- Chloroquine Diphosphate
- Placebo oral tablet
-
Manaus, Amazonas, BrazilHospital e Pronto Socorro Delphina Rinaldi Abdel Aziz
Aug 2, 2021
Viral Pneumonia, Nitric Oxide, Respiratory Disease Trial in Jerusalem, Petah Tikva (LungFit™)
Completed
- Viral Pneumonia
- +6 more
- LungFit™
-
Jerusalem, Israel
- +2 more
Dec 14, 2022
SARS CoV 2 Infection, Alveolar; Injury, Children Trial in Istanbul
Completed
- SARS CoV 2 Infection
- +3 more
-
Istanbul, TurkeyHaseki Training and Research Hospital
Nov 17, 2022
Severe ARDS on COVID-19 Pneumonia Requiring Mechanical
Active, not recruiting
- Covid19
-
Paris, FranceGroupe Hospitalier Paris Saint-Joseph
Mar 30, 2022
Corona Virus Infection, ARDS Due to Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2, Oxygen Deficiency Trial
Not yet recruiting
- Corona Virus Infection
- +2 more
- Oxygen theraphy with high flow nasal cannule
- Oxygen theraphy with mask with reservoir
-
Szczecin, Zachodniopomorskie, PolandOxygen Therapy Sector of Temporary Hospital
Jan 18, 2022
Acute Respiratory Distress Syndrome, ARDS (Moderate or Severe), COVID-19 Pneumonia Trial in Minneapolis, Pittsburgh (Mesenchymal
Active, not recruiting
- Acute Respiratory Distress Syndrome
- +2 more
- Mesenchymal stromal cells
- Placebo
-
Minneapolis, Minnesota
- +1 more
Feb 25, 2022
Clinical Characteristics and Outcomes of Pediatric COVID-19
Completed
- COVID-19
- +4 more
- Exposure (not intervention) - SARS-CoV-2 infection
-
Calgary, Alberta, CanadaUniversity of Calgary/Alberta Children's Hospital
May 16, 2022
COVID-19 Pneumonia, COVID-19 Respiratory Infection, COVID-19 Acute Bronchitis Trial in Worldwide (Not applicable (observational
Recruiting
- COVID-19 Pneumonia
- +17 more
- Not applicable (observational study)
-
Antwerpen, Belgium
- +6 more
Dec 14, 2021
Plasma SARS-CoV-2 RNA Levels in Critically Ill COVID-19 Patients
Not yet recruiting
- COVID-19 Pneumonia
- ARDS Due to Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2
- plasmatic SARS-CoV-2 RNA quantification
- (no location specified)
Nov 9, 2021
Infection Control for Severe Acute Respiratory Syndrome
Completed
- Covid19
- +4 more
-
Dubai, United Arab EmiratesNMC Specialty Hospital
May 9, 2021
Covid19, COVID-19 Pneumonia, COVID-19 Respiratory Infection Trial in Everett (N-acetylcysteine, Placebo)
Not yet recruiting
- Covid19
- +7 more
- N-acetylcysteine
- Placebo
-
Everett, MassachusettsCambridge Health Alliance
Jan 20, 2022
Severe Acute Respiratory Syndrome Coronavirus 2 Trial in Suita (Mesenchymal stem cell)
Completed
- Severe Acute Respiratory Syndrome Coronavirus 2
- Mesenchymal stem cell
-
Suita, Osaka, JapanOsaka University Hospital
Mar 16, 2021
Pneumonitis, SARS-CoV Infection Trial in Worldwide (GLS-1027, Placebo)
Active, not recruiting
- Pneumonitis
- SARS-CoV Infection
- GLS-1027
- Placebo
-
Baton Rouge, Louisiana
- +16 more
Jan 10, 2023
SARS-CoV-2/COVID-19 Related Pneumonia on Lung Function and
Unknown status
- Covid19
- +3 more
-
Warsaw, Mazowieckie, PolandNational Institute for Tuberculosis and Lung Diseases
Jun 9, 2021
Pulmonary Fibrosis During Severe COVID-19 Pneumonia
Active, not recruiting
- Severe Acute Respiratory Syndrome Coronavirus 2
- +2 more
- Aminoterminal type III peptide of procollagen
- Lung computed tomography
-
Marseille, FranceHopital Europeen Marseille
Aug 7, 2022